Abstract:OBJECTIVE:To investigate the potential of hepatitis C virus (HCV) antibody measurement as a clinical approach to determine the infection status and potential for spontaneous-resolution among patients with HCV mono-infection and HCV/human immunodeficiency virus (HIV) co-infection.METHODS:A total of 340 individuals who tested positive for serum anti-HCV antibodies and/or serum anti-HW antibodies were enrolled for study in 2009 from a single village in central China. Markers of liver function (alanine aminotransferase (ALT) and aspartate aminotransferase (AST)) and infection (anti-HCV antibodies, CD4⁺ T cell counts, HCV genotype, and HCV viral load) were measured at baseline and follow-up (in July 2012). At follow-up,the subjects were grouped according to ongoing HCV mono-infection (n=129), ongoing HCV/HIV co-infection (n=98), spontaneously resolved (SR)-HCV in mono-infection (n=65), and SR-HCV in HCV/HIV co-infection (n=48) for statistical analysis.RESULTS:Almost all of the subjects in the ongoing HCV mono-infection group showed high levels of HCV antibodies (S/CO more than or equal to 10), but the majority of the subjects in the SR-HCV in mono-infection group and in the ongoing HCV/HIV co-infection group. The SR-HCV mono-infection group showed a remarkable decrease in HCV antibodies from 2009 (HIV:7.75 ± 3.8; HIV+:7.61 ± 3.47) to 2012 (HIV:5.51 ± 3.67; HIW:4.93 ± 3.35) (HIV:t =10.67, P less than 0.01; HIV+:t =9.52, P less than 0.01). The ongoing HCV/HIV co-infection group showed a positive correlation between HCV antibodies S/CO ratio and CD4⁺ T cell count (r=028, P=0.008). In the ongoing HCV mono-infection group,the levels of HCV antibodies were significantly higher in individuals infected with HCV-1b than in those with HCV-2a (14.74 ± 1.68 vs.14.08 ± 1.44, t=2.20, P=0.03). In the ongoing HCV/HIV co-infection group, the numbers of subjects with elevated (more than 40 U/L) liver function markers were significantly different according to the HCV genotype infection:HCV-1b:ALT, 25/42 vs.16/56 (x²=9.45, P=0.002); HCV2a:AST, 28/42 vs.18/56 (x²=11.49, P=0.001). The HCV RNA positive rate was significantly higher in subjects with high HCV antibody cutoff values (S/CO more than or equal to 10) than in those with low HCV antibody (S/CO less than 10) (HIV:128/151 vs.1/43, x²=102.11, P less than 0.01; HIV+:88/98 vs.10/48, x²=69.44, P less than 0.01), regardless of HIV co-infection. Significantly more subjects in the ongoing HCV mono-infection group had elevated (more than 40 U/L) ALT or AST than the subjects in the SR-HCV mono-infection group with high levels of HCV antibody (S/CO more than or equal to 10) (ALT:57/128 vs.2/23, x²=10.52, P=0.001; AST:57/128 vs.0/23, x²=16.45, P less than 0.01).CONCLUSION:Serum HCV antibody levels, in combination with other clinical information such as liver function and HIV infection status, may aid in the preliminarily evaluation of an individual's HCV infection status and likelihood for spontaneous resolution. Low levels of HCV antibody (S/CO less than 10) may indicate a better chance of SR-HCV, after ruling out the possibility of suffering from immunosuppressive diseases such as HIV infection.

Detection of Serum Anti-F in Hepatitis C Virus Infected Patients

[Detection of Serum Anti-F Antibody in Hepatitis C Virus Infected Patients].

Detection of Hepatitis B Virus Large Surface Protein Using a Time‐Resolved Immunofluorometric Assay

Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.

Serum Fetuin A Level is Associated with Nonalcoholic Fatty Liver Disease in Chinese Population

Clinical Significance of Joint Detection of HCV-RNA and Anti-Hcv in Diagnosis of Hepatitis C

Analysis on the prevalence of anti-HCV infection in different populations in Qidong Area

[Detection of Hepatitis C Virus Antibody in Saliva and Its Clinical Significance].

Study on the Significance of S/Co Ratio of a Domestic Reagent Used for Anti-Hepatitis C Virus Antibody Detection

Serum Autoantibodies of Patients with Chronic Hepatitis C and the Significance Thereof in Infection of Hepatitis C Virus

Clinical application of enzyme immunoassay for the detection of hepatitis C virus core antigen

Viral Hepatitis (HBV and HCV) Background in Chinese Patients with Hepatocellular Carcinoma

Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.

Characterization of the Specific CD4+ T Cell Response Against the F Protein During Chronic Hepatitis C Virus Infection.

A Higher Correlation Of Hcv Core Antigen With Cd4+T Cell Counts Compared With Hcv Rna In Hcv/Hiv-1 Coinfected Patients

[Seroepidemiological Investigation of Hepatitis C Virus in Zhejiang Province: a Hospital-Based Study].

Retrospective analysis of non-A-E hepatitis: possible role of hepatitis B and C virus infection.

[A Preliminary Assessment of the Clinical Utility of Measuring Hepatitis C Virus Antibody to Evaluate Infection Status].

Establishment and methodological evaluation of a chemiluminescence assay for detection of anti‐envelope protein (E1, E2) antibodies in the serum of hepatitis C virus‐infected patients

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection

Study of relationsip between FAS antigen expression and HCV RNA level in patients with chronic hepatitis C